Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.240
-0.060 (-4.62%)
Mar 26, 2026, 4:00 PM EDT - Market closed
Pulmonx Revenue
In the year 2025, Pulmonx had annual revenue of $90.50M with 8.01% growth. Pulmonx had revenue of $22.60M in the quarter ending December 31, 2025, a decrease of -4.91%.
Revenue (ttm)
$90.50M
Revenue Growth
+8.01%
P/S Ratio
0.58
Revenue / Employee
$305,733
Employees
296
Market Cap
52.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 90.50M | 6.71M | 8.01% |
| Dec 31, 2024 | 83.79M | 15.11M | 22.01% |
| Dec 31, 2023 | 68.68M | 15.01M | 27.98% |
| Dec 31, 2022 | 53.66M | 5.25M | 10.84% |
| Dec 31, 2021 | 48.42M | 15.68M | 47.91% |
| Dec 31, 2020 | 32.73M | 138.00K | 0.42% |
| Dec 31, 2019 | 32.60M | 12.59M | 62.94% |
| Dec 31, 2018 | 20.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Outset Medical | 119.48M |
| LENSAR | 59.14M |
| Cytosorbents | 36.98M |
| electroCore | 32.03M |
| Sensus Healthcare | 27.48M |
| Spectral AI | 19.65M |
| Elutia | 12.29M |
LUNG News
- 22 days ago - Pulmonx Corporation (LUNG) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 22 days ago - Pulmonx Announces Closing of up to $60 Million Credit Facility - GlobeNewsWire
- 4 weeks ago - Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - GlobeNewsWire
- 4 months ago - Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Pulmonx Corporation (LUNG) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Pulmonx Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025 - GlobeNewsWire